Ublituximab lowers incidence of relapse and number of brain lesions in relapsing multiple sclerosis

Retrieved on: 2022-08-26 19:14:11

Tags for this article:

Click the tags to see associated articles and topics

Ublituximab lowers incidence of relapse and number of brain lesions in relapsing multiple sclerosis. View article details on hiswai:

Excerpt

B-cell antigen-specific monoclonal antibodies have demonstrated therapeutic effects for patients with multiple sclerosis.

Article found on: www.2minutemedicine.com